Mid-life structural changes to the jawbone may signal subsequent height loss in women, suggests research published in the open access journal BMJ Open.
Eisai lowers Leqembi revenue forecast after rocky entry to market – Pharmaceutical Technology
Leqembi is forecasted to make $4.2bn globally by 2030. Image credit: Shutterstock / viewimage. Eisai has lowered the sales forecast for its Alzheimer’s drug Leqembi